Biochemistry, Genetics and Molecular BiologyCancer Research• Life Sciences
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Publisher: Cognizant Communication Corporation
ISSN: 0965-0407;1555-3906
OpenAlex H-Index68
Total Citations37,521
Published Works2,147
Tracked Guidelines0 rules
Research Article WordsField median is 5,300 w
3,000 words
Abstract LimitStructured or unstructured
400 words
Reference CapIn bibliography list
50 references
Figures & TablesCheck supplement rules
Unrestricted items
Visual Benchmark Diagram
This Journal: 3,000 wordsWord Limit Position Relative to Biochemistry, Genetics and Molecular Biology Field Spectrum
P25: 3,710w
Field Median: 5,300w
P75: 6,890w
📍 3,000 w
This journal's word cap sits below the median of 5,300 words for journals in Biochemistry, Genetics and Molecular Biology.
Rule Composition for Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Categorical distribution of the 0 submission constraints tracked for this journal.
Manuscript Types Word Limits Comparison
Length allowances across different paper formats published by Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.
Single word limit applies universally across all article types.
Full Submission Requirements by Manuscript Type
Normalized submission requirements extracted from the official author guidelines.
No specific numeric rules published in author guidelines for this journal.